The University of Texas Health Science Center at San Antonio

10/08/2024 | Press release | Distributed by Public on 10/08/2024 08:02

Mays Cancer Center hosts annual liver cancer symposium

FOR IMMEDIATE RELEASE

Oct. 8, 2024

Contact: Eileen Teves, 210-450-7239, [email protected]

MEDIA ADVISORY

Highlights clinical breakthroughs and support for at-risk communities

WHAT: Mays Cancer Center at UT Health San Antonio will host the fourth annual San Antonio Liver Cancer Symposium.

The two-day symposium will feature presentations from liver cancer experts from leading cancer centers across the country. Topics include managing pediatric liver cancer, the future of liver cancer screening and optimal surveillance, the latest advancements in surgery, transplantation and interventional radiology, caregiver support and more. Read the full agenda

Registration: MaysCancerCenter.org/SALCS2024

WHEN: Friday, Oct. 11 and Saturday, Oct. 12

Registration: 7 a.m.

Welcome and Introductions start: 7:50 a.m.

Presentations begin: 8 a.m.

WHERE: Hilton Palacio del Rio, 200 S. Alamo St., San Antonio, TX 78205

WHO: Primary care providers, oncology nurses, researchers and transplant surgeons; plus surgical, medical, and radiation oncologists

Interviews available in advance or at the event:

Sukeshi Patel Arora, MD, co-director of San Antonio Liver Cancer Symposium, associate professor in the Division of Hematology and Medical Oncology at UT Health San Antonio and leader of the gastrointestinal malignancies and geriatric oncology program at Mays Cancer Center at UT Health San Antonio.

Danielle Fritze, MD, co-director of San Antonio Liver Cancer Symposium, clinical associate professor of surgery and director of general surgery residency associate program at Mays Cancer Center at UT Health San Antonio.

WHY: Liver disease may cause inflammation and mutations that lead to cancer. Building a community-based liver cancer program to improve early detection and diagnosis will be top of mind at the symposium.

Those interested may find the event helpful in improving their knowledge of the clinical treatment of liver cancer, plus receive comprehensive updates on the most current advances in research and important information.

Attendees will have opportunities to participate in discussions led by clinicians and researchers, connect with renowned experts in liver cancer and earn Continuing Medical Education (CME), Maintenance of Certification (MOC) and Commission on Collegiate Nursing Education (CNE) credits.

NOTES: October is National Liver Cancer Awareness Month, a time to recognize and support people affected by liver cancer, and to remind the community about the risks, prevention, screening and treatment.

According to the American Cancer Society, cancer is the second leading cause of death among Hispanic people, accounting for 17% of deaths. Compared to non-Hispanic whites, Hispanic men and women are more likely to develop cancer in the liver.

The most common form of liver cancer in adults is hepatocellular carcinoma (HCC), which can start as a single tumor that grows larger, or as many small cancer nodules throughout the liver.

  • About 41,630 news cases (28,000 in men and 13,630 in women) will be diagnosed.
  • About 29,840 people (19,120 men and 10,720 women) will die of these cancers.

Some risk factors include obesity, alcoholism and poor lifestyle choices.